Artivion (NYSE:AORT) Rating Increased to Strong-Buy at Citizens Jmp
Artivion (NYSE:AORT – Get Free Report) was upgraded by equities researchers at Citizens Jmp to a “strong-buy” rating in a research report issued on Tuesday,Zacks.com reports. Several other equities analysts also recently commented on AORT. Stifel Nicolaus lowered their price objective on shares of Artivion from $33.00 to $30.00 and set a “buy” rating for […]
